NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 253

Clinical Trials Chronic Pain Cannabinoids Patients 253

Cannabis Law Report

AUGUST 17, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. We believe the totality of the data is encouraging and supports advancing to Phase 3. Data Highlights. About Marinus Pharmaceuticals. Marinus Pharmaceuticals, Inc. Conference call and webcast to be held today at 4:30 p.m.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. physicians began over-prescribing opioids like oxycodone due to reassurance from pharmaceutical companies that they were not addictive—which patients quickly discovered to be untrue.

Programs 52

Programs Chronic Pain Treatment Conditions 52

The Cannigma

NOVEMBER 23, 2021

The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects. We delve into how data can further our understanding of different types of cannabis and why standardization is desperately needed in the industry. 0:14:10.3]

Data 52

Data Patients Access Wellness and Beauty 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. “Our 917 280 2424 / 401 500 6570.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

SEPTEMBER 8, 2021

Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. For more information, please visit www.trutrace.co.

Supply Chain 95

Supply Chain Pharmaceutical Seed-To-Sale Events 95

Puff Puff Post

SEPTEMBER 16, 2019

Santé Cannabis, a pioneer in medical cannabis in Québéc , has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (TSX: WEED) (NYSE: CGC) to launch the Prescriber Training Program, designed to aid physicians and patients, announced today at the new Santé Cannabis clinic and research centre in Montréal.

Programs 108

Programs Research and Development Education Treatment 108

Cannabis Law Report

JULY 27, 2021

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Veriheal

FEBRUARY 21, 2023

” Restricting qualifying conditions also results in limited data collection, hindering the collective understanding of medical cannabis. Furthermore, Nugg MD’s data shows just how vital MMJ access has become in modern society’s health landscape. Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

NOVEMBER 15, 2021

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. Finally, we recently acquired the worldwide rights to VRP324, which is an intranasal pharmaceutical-grade cannabidiol product candidate for the management of epilepsy in children (rare pediatric disease) and adults. About Virpax Pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

AUGUST 3, 2021

Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Medxtractor Corp.

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

AUGUST 29, 2021

The export to Brazil also confirms the regulatory pathway and acts as a proof of concept in the largest market in South America where we aim to establish long-lasting supply relationships with our Brazilian pharmaceutical partners.”. 1 Source: Passport, Euromonitor International, Cannabis in Latin America, July 2021.

Extraction 98

Extraction Supply Chain Research and Development CBD 98

Cannabis Law Report

AUGUST 1, 2022

Love it or hate it, social media can be a powerful tool for education and data collection. At the time, Shields was living in Boston and Kirk was finishing up graduate school and working as a teaching assistant at the University of Rhode Island’s cannabis program. “I Today, she has over 378,000 followers ( @cannabichem ).

Education 52

Education Access Media Data 52

NORML

AUGUST 26, 2019

So, it shouldn’t be a huge surprise that Virginia didn’t launch a medical marijuana program until 2015, nearly two decades after California. And it took extensive, concerted efforts from marijuana law reform organizations like NORML to negotiate with Virginia’s Republican Party to get the program finally running.

Marijuana 216

Marijuana Legalization Programs Oil 216

MMJ Recs

NOVEMBER 17, 2023

The community impact is visible in several key areas: Healthcare Advancements MMJ has expanded the range of treatment options available to patients, offering an alternative to conventional pharmaceuticals. The state’s program has evolved to meet the needs of patients and the demands of the industry.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JUNE 19, 2022

Unlike novel chemical compounds that are synthetically produced in the pharmaceutical industry through drug development programs, psychedelic compounds have a long and established history. But evaluating the promise, and the risk, of a psychedelics IP portfolio is still mired in unknowns.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

United Patients Group

JANUARY 4, 2024

They bridge the gap between technology and healthcare, ensuring the secure and efficient collection, storage, analysis, and utilization of patient data. They work on implementing and maintaining electronic health records (EHRs), developing data-driven solutions, and training healthcare professionals on using technology effectively.

Research and Development 52

Research and Development Patients Data Policy 52

Cannabis Law Report

OCTOBER 12, 2021

Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. Leveraging its deep expertise in nucleic acid-based technologies, the Company has also established safeCircle™, a pooled COVID-19 testing program that is grounded in the Company’s EUA-authorized Linea™ COVID-19 Assay Kit.

Programs 52

Programs Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JULY 29, 2021

With Avicanna’s dedication to quality standards and pharmaceutical positioning we are poised to be a significant long-term player in the European medical market that is predominantly focused on medical utility of cannabinoids and where meeting EU pharmacopeia standards are essential.”.

Extraction 98

Extraction Supply Chain THC Research and Development 98

Cannabis Law Report

JUNE 18, 2021

Minimum of 5 years of relevant industry experience in biotechnology or pharmaceutical companies demonstrating strong data mining and filtering skills. Global Data, PitchBook) to prepare competitive analysis assessments on new technologies. Global Data, PitchBook) to prepare competitive analysis assessments on new technologies.

Business 104

Business Research and Development Advocacy Data 104

Canna Law Blog

SEPTEMBER 6, 2023

We should also see other professional conduct rules for the physicians, healthcare providers, and pharmacists who prescribe and supply approved forms of cannabis, including mandatory drug monitoring programs. Most say that the current state-legal programs won’t be impacted by a reschedule. So, you do the political math there.

Research and Development 114

Research and Development DEA Marijuana Pharmaceutical 114

The Cannigma

FEBRUARY 1, 2023

Unlike healthy cells, these abnormal cells don’t die as they are typically programmed to do, and instead begin to grow and divide uncontrollably, effectively circumventing the body’s normal checks and balances. So until now, we have been missing an important area of research, which is real world data of people using cannabinoids.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Canna Law Blog

JULY 15, 2019

Currently, seven of Canada’s top ten cannabis patent holders are major multi-national pharmaceutical companies, according to a joint research project by Washington D.C.-based based New Frontier Data and London-based cannabis bio-technology firm, Grow Biotech. As we’ve referenced before , data shows that the number of U.S.

Pharmaceutical 93

Pharmaceutical Research and Development Data Cannabinoids 93

Puff Puff Post

SEPTEMBER 16, 2019

Santé Cannabis, a pioneer in medical cannabis in Québéc , has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (TSX: WEED) (NYSE: CGC) to launch the Prescriber Training Program, designed to aid physicians and patients, announced today at the new Santé Cannabis clinic and research centre in Montréal.

Programs 40

Programs Research and Development Education Treatment 40

Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

The Cannigma

AUGUST 5, 2022

When antidepressants were first introduced in the mid-20 th century, they were a breakthrough in pharmaceuticals. Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” But this program offers more than just the ketamine itself.

Treatment 138

Treatment Research and Development Therapy Digestion 138

Cannabis Law Report

AUGUST 11, 2021

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments. They are a great strategic fit. and Santa Marta Golden Hemp S.A.S.,

Topical 98

Topical Research and Development Seed-To-Sale Pharmaceutical 98

Veriheal

AUGUST 11, 2021

This generation is also on track to become the most educated generation yet with the majority being likely to enroll in post-high school programs. The news outlet used data from Headset to explain that Gen Z women who purchased cannabis grew by 151%, with the Gen Z men sitting at a 118% increase in legal purchases.

Data 104

Data Cannabis Programs Pharmaceutical 104

Cannabis Law Report

DECEMBER 20, 2021

Data To Support Regulatory Filings in the United States. –(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. First Patient Expected to be Enrolled by Q2 of 2022. BERWYN, Pa.–(BUSINESS For more information, please visit www.virpaxpharma.com. About Altasciences.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

JULY 28, 2021

The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

SEPTEMBER 26, 2021

Identify regulatory submission pathways and data requirements for new license and amendment submissions. pharmaceutical, biotechnology, science, chemistry, microbiology or biology). Minimum 3 years relevant regulatory/compliance experience in a regulated environment, preferably in cannabis, health products, pharmaceutical, food (i.e.

Environment 52

Environment Compliance Compliance Pharmaceutical 52

Veriheal

AUGUST 31, 2020

Program between St. About Sinibaldo: Sinibaldo is an aspiring healthcare professional and a biomedical researcher in the Medical Scientist Training Program (M.D./Ph.D.) About Nishtha: Nishtha is pursuing neurology to become a physician-scientist in honor of her grandmother Nani who suffered from Alzheimer’s.

Research and Development 117

Research and Development Education Agriculture Patients 117

Veriheal

APRIL 1, 2022

Early success with medical cannabis has contributed to the market’s rising popularity among local German people, with up-to-date figures showing that at least 128,000 people have registered to receive cannabis-based medicines every single year under the patient program. What’s more, analysts foresee the market inflating to €7.7

Recreational 96

Recreational Business Legalization Seed-To-Sale 96

Cannabis Law Report

JUNE 16, 2021

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Veriheal

DECEMBER 24, 2021

One of the original authors of the Compassionate Use of Medical Cannabis Pilot Program Act in 2013 (MCPP) — a law that led to the legalization of pharmaceutical-grade cannabis across the state of Illinois — says that growing demand and acceptance of the federally illegal plant has not reduced the risk of job loss.

Legislation 98

Legislation Recreational Patients Cannabis 98

SpeedWeed

AUGUST 11, 2021

The grant comes from Michigan’s 2021 Veteran Marijuana Research Grant Program , and is funded by the state’s recreational cannabis taxes. If so, we will seek to return that generosity by developing a public-benefit cannabis pharmaceutical product that would be eligible for insurance coverage, just like any other pharmaceutical drug.”.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

SpeedWeed

JULY 8, 2021

Michigan and Massachusetts continue to make strong showings as their programs continue to grow. . Manufacturers have the best opportunity to build a brand, and this makes it an attractive part of the value chain for transplanted talent from liquor, packaged goods, and pharmaceuticals because it seems familiar. . View original article.

Media 52

Media Data Retail Concentrates 52